FENC

Fennec Pharmaceuticals (FENC)

About Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Details

Daily high

$7.12

Daily low

$6.86

Price at open

$6.99

52 Week High

$9.92

52 Week Low

$5.65

Market cap

242.4M

Dividend yield

0.00%

Volume

37,071

Avg. volume

137,324

P/E ratio

-20.43

Fennec Pharmaceuticals News